HomeAI · summaries
Storia in 4 fonti
Diabetes drug Ozempic will cost half-price for US patients paying cash
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Ozempic sales surge ‘up to 600%’ after Mounjaro price rises
Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to 'almost as good' competitor
- ·
cnbc.com
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Patients can pay $499 in cash per month for three dose sizes of Ozempic through the company's direct-to-consumer pharmacy and GoodRx, among other platforms.
